
    
      An Open-label, Nonrandomised, Phase I Study to Assess the Pharmacokinetics of Ceftaroline
      After Intravenous Administration of aSingle Dose of Ceftaroline Fosamil (200 mg) to Patients
      with End-stage Renal Disease Undergoing Haemodialysis when Compared to a Single Dose of
      Ceftaroline Fosamil (600 mg)
    
  